Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer

Published:2019-06 Issue:3 Volume:10 Page:412-420
ISSN:2078-6891
Container-title:Journal of Gastrointestinal Oncology
language:
Short-container-title:J. Gastrointest. Oncol

Author:

Amin Manik,Desai Monica,Trinkaus Kathryn,Brown Amberly,Wang-Gillam Andrea,Tan Benjamin,Picus Joel,Sorscher Steven,Highkin Maureen,Lears Kim,Lockhart Albert C.

Publisher

AME Publishing Company

Subject

Gastroenterology,Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing of H1-receptor antagonists (levo)cetirizine, (des)loratadine, and fexofenadine as a case study for systematic analysis of trials on clinicaltrials.gov using semi-automated processes with custom-coded software;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-10-23

2. A study on metabolic characteristics and metabolic markers of gastrointestinal tumors;Cancer Biology & Therapy;2023-09-13

3. Prognostic characteristics of T-cell mediated cell killing-related genes in lung adenocarcinoma;Autoimmunity;2023-08-25

4. Performance of capecitabine in novel combination therapies in colorectal cancer;Journal of Chemotherapy;2021-05-21

5. Comprehensive analysis of expression profiles of long non‑coding RNAs with associated ceRNA�network involved in gastric cancer progression;Molecular Medicine Reports;2019-07-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP